Common Stock, Shares, Outstanding of Bionano Genomics, Inc. from 31 Dec 2017 to 30 Sep 2025

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
Bionano Genomics, Inc. quarterly Common Stock, Shares, Outstanding in shares history and change rate from 31 Dec 2017 to 30 Sep 2025.
  • Bionano Genomics, Inc. Common Stock, Shares, Outstanding for the quarter ending 30 Sep 2025 was 9,730,400, a 89% decline year-over-year.
Source SEC data
View on sec.gov
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Change (%)

Bionano Genomics, Inc. Quarterly Common Stock, Shares, Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 9,730,400 -78,737,600 -89% 30 Sep 2025 10-Q 13 Nov 2025 2025 Q3
Q2 2025 3,909,400 -66,866,600 -94% 30 Jun 2025 10-Q 14 Aug 2025 2025 Q2
Q1 2025 3,101,400 -54,437,600 -95% 31 Mar 2025 10-Q 14 May 2025 2025 Q1
Q4 2024 1,865,400 +1,102,867 +145% 31 Dec 2024 10-Q 13 Nov 2025 2025 Q3
Q3 2024 88,468,000 +53,119,000 +150% 30 Sep 2024 10-Q 14 Nov 2024 2024 Q3
Q2 2024 70,776,000 +37,536,000 +113% 30 Jun 2024 10-Q 07 Aug 2024 2024 Q2
Q1 2024 57,539,000 -249,251,000 -81% 31 Mar 2024 10-Q 08 May 2024 2024 Q1
Q4 2023 762,533 -28,955,467 -97% 31 Dec 2023 10-K 31 Mar 2025 2024 FY
Q3 2023 35,349,000 -261,551,000 -88% 30 Sep 2023 10-Q 08 Nov 2023 2023 Q3
Q2 2023 33,240,000 -256,821,000 -89% 30 Jun 2023 10-Q 09 Aug 2023 2023 Q2
Q1 2023 306,790,000 +17,102,000 +5.9% 31 Mar 2023 10-Q 09 May 2023 2023 Q1
Q4 2022 29,718,000 -259,884,000 -90% 31 Dec 2022 10-K 05 Mar 2024 2023 FY
Q3 2022 296,900,000 +15,459,000 +5.5% 30 Sep 2022 10-Q 03 Nov 2022 2022 Q3
Q2 2022 290,061,000 +11,007,000 +3.9% 30 Jun 2022 10-Q 04 Aug 2022 2022 Q2
Q1 2022 289,688,000 +10,894,000 +3.9% 31 Mar 2022 10-Q 05 May 2022 2022 Q1
Q4 2021 289,602,000 +99,649,000 +52% 31 Dec 2021 10-K 09 Mar 2023 2022 FY
Q3 2021 281,441,000 +133,093,000 +90% 30 Sep 2021 10-Q 04 Nov 2021 2021 Q3
Q2 2021 279,054,000 +187,079,000 +203% 30 Jun 2021 10-Q 04 Aug 2021 2021 Q2
Q1 2021 278,794,000 +241,042,000 +638% 31 Mar 2021 10-Q 13 May 2021 2021 Q1
Q4 2020 189,953,000 +155,678,531 +454% 31 Dec 2020 10-K 01 Mar 2022 2021 FY
Q3 2020 148,348,000 +137,450,478 +1261% 30 Sep 2020 10-Q 13 Nov 2020 2020 Q3
Q2 2020 91,975,000 +81,077,478 +744% 30 Jun 2020 10-Q 13 Aug 2020 2020 Q2
Q1 2020 37,752,000 +26,906,980 +248% 31 Mar 2020 10-Q 18 Jun 2020 2020 Q1
Q4 2019 34,274,469 +24,219,397 +241% 31 Dec 2019 10-K 23 Mar 2021 2020 FY
Q3 2019 10,897,522 +864,835 +8.6% 30 Sep 2019 10-Q 07 Nov 2019 2019 Q3
Q2 2019 10,897,522 30 Jun 2019 10-Q 08 Aug 2019 2019 Q2
Q1 2019 10,845,020 31 Mar 2019 10-Q 09 May 2019 2019 Q1
Q4 2018 10,055,072 +9,977,815 +12915% 31 Dec 2018 10-K 10 Mar 2020 2019 FY
Q3 2018 10,032,687 30 Sep 2018 10-Q 07 Nov 2018 2018 Q3
Q4 2017 77,257 31 Dec 2017 10-K 14 Mar 2019 2018 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.